Alkylating Drug [EPC]

165918 reported adverse events

Drugs of this class: BUSULFAN TEMOZOLOMIDE MITOMYCIN THIOTEPA IFOSFAMIDE CYCLOPHOSPHAMIDE DACARBAZINE CARMUSTINE CHLORAMBUCIL LOMUSTINE LURBINECTEDIN

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 12394
1 OFF LABEL USE 11347
2 NEUTROPENIA 10040
3 PYREXIA 9136
4 THROMBOCYTOPENIA 7100
5 PRODUCT USE IN UNAPPROVED INDICATION 6524
6 NAUSEA 6484
7 DRUG INEFFECTIVE 6313
8 DIARRHOEA 6026
9 PNEUMONIA 5983
See all common reactions for Alkylating Drug [EPC]

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENGRAFTMENT SYNDROME 260 0.6989
1 CYSTITIS VIRAL 126 0.6562
2 B-CELL TYPE ACUTE LEUKAEMIA 103 0.5722
3 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 578 0.5683
4 ENGRAFT FAILURE 128 0.5664
5 ACUTE GRAFT VERSUS HOST DISEASE 1945 0.5578
6 VENOOCCLUSIVE DISEASE 996 0.5567
7 IDIOPATHIC PNEUMONIA SYNDROME 107 0.5544
8 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 209 0.5457
9 BONE MARROW TRANSPLANT REJECTION 104 0.5417
See all enriched reactions for Alkylating Drug [EPC]